
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Enhancement of doxorubicin efficacy by diosmetin through DNA damage accumulation and P-glycoprotein inhibition in breast cancer cells - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="AE5334198AF28663053419007DDA6C06.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="scirep">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371033/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Scientific Reports">
<meta name="citation_title" content="Enhancement of doxorubicin efficacy by diosmetin through DNA damage accumulation and P-glycoprotein inhibition in breast cancer cells">
<meta name="citation_author" content="Monika Michalczyk">
<meta name="citation_author_institution" content="Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland">
<meta name="citation_author" content="Ewelina Humeniuk">
<meta name="citation_author_institution" content="Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland">
<meta name="citation_author" content="Joanna Kubik">
<meta name="citation_author_institution" content="Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland">
<meta name="citation_author" content="Grzegorz Adamczuk">
<meta name="citation_author_institution" content="Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland">
<meta name="citation_author" content="Mariola Michalczuk">
<meta name="citation_author_institution" content="Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland">
<meta name="citation_author" content="Barbara Madej-Czerwonka">
<meta name="citation_author_institution" content="Human Anatomy Department, Faculty of Medicine, Medical University of Lublin, 4 Jaczewskiego, Lublin, 20-090 Poland">
<meta name="citation_author" content="Maciej Czerwonka">
<meta name="citation_author_institution" content="First Department of Surgery, Jagiellonian University Medical College, 2 Jakubowskiego, Krakow, 30-688 Poland">
<meta name="citation_author" content="Agnieszka Korga-Plewko">
<meta name="citation_author_institution" content="Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="15">
<meta name="citation_firstpage" content="30814">
<meta name="citation_doi" content="10.1038/s41598-025-16681-3">
<meta name="citation_pmid" content="40841424">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371033/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371033/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371033/pdf/41598_2025_Article_16681.pdf">
<meta name="description" content="Doxorubicin (DOX) is widely used in treatment; however, its efficacy is often compromised by multidrug resistance (MDR), limiting therapeutic outcomes. This study investigates the anticancer potential of diosmetin (DT), a metabolite of diosmin ...">
<meta name="og:title" content="Enhancement of doxorubicin efficacy by diosmetin through DNA damage accumulation and P-glycoprotein inhibition in breast cancer cells">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Doxorubicin (DOX) is widely used in treatment; however, its efficacy is often compromised by multidrug resistance (MDR), limiting therapeutic outcomes. This study investigates the anticancer potential of diosmetin (DT), a metabolite of diosmin ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371033/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12371033">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1038/s41598-025-16681-3"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/41598_2025_Article_16681.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371033%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12371033/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12371033/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371033/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-scirep.jpg" alt="Scientific Reports logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Scientific Reports" title="Link to Scientific Reports" shape="default" href="http://www.nature.com/srep" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Sci Rep</button></div>. 2025 Aug 21;15:30814. doi: <a href="https://doi.org/10.1038/s41598-025-16681-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1038/s41598-025-16681-3</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Sci%20Rep%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Sci%20Rep%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Sci%20Rep%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Enhancement of doxorubicin efficacy by diosmetin through DNA damage accumulation and P-glycoprotein inhibition in breast cancer cells</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Michalczyk%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Monika Michalczyk</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Monika Michalczyk</span></h3>
<div class="p">
<sup>1</sup>Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Michalczyk%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Monika Michalczyk</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Humeniuk%20E%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Ewelina Humeniuk</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Ewelina Humeniuk</span></h3>
<div class="p">
<sup>1</sup>Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Humeniuk%20E%22%5BAuthor%5D" class="usa-link"><span class="name western">Ewelina Humeniuk</span></a>
</div>
</div>
<sup>1,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kubik%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Joanna Kubik</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Joanna Kubik</span></h3>
<div class="p">
<sup>1</sup>Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kubik%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joanna Kubik</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adamczuk%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Grzegorz Adamczuk</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Grzegorz Adamczuk</span></h3>
<div class="p">
<sup>1</sup>Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Adamczuk%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Grzegorz Adamczuk</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Michalczuk%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Mariola Michalczuk</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Mariola Michalczuk</span></h3>
<div class="p">
<sup>1</sup>Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Michalczuk%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Mariola Michalczuk</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Madej-Czerwonka%20B%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Barbara Madej-Czerwonka</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Barbara Madej-Czerwonka</span></h3>
<div class="p">
<sup>2</sup>Human Anatomy Department, Faculty of Medicine, Medical University of Lublin, 4 Jaczewskiego, Lublin, 20-090 Poland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Madej-Czerwonka%20B%22%5BAuthor%5D" class="usa-link"><span class="name western">Barbara Madej-Czerwonka</span></a>
</div>
</div>
<sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Czerwonka%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Maciej Czerwonka</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Maciej Czerwonka</span></h3>
<div class="p">
<sup>3</sup>First Department of Surgery, Jagiellonian University Medical College, 2 Jakubowskiego, Krakow, 30-688 Poland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Czerwonka%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Maciej Czerwonka</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Korga-Plewko%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Agnieszka Korga-Plewko</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Agnieszka Korga-Plewko</span></h3>
<div class="p">
<sup>1</sup>Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Korga-Plewko%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Agnieszka Korga-Plewko</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Independent Medical Biology Unit, Medical University of Lublin, 8b Jaczewskiego, Lublin, 20-090 Poland </div>
<div id="Aff2">
<sup>2</sup>Human Anatomy Department, Faculty of Medicine, Medical University of Lublin, 4 Jaczewskiego, Lublin, 20-090 Poland </div>
<div id="Aff3">
<sup>3</sup>First Department of Surgery, Jagiellonian University Medical College, 2 Jakubowskiego, Krakow, 30-688 Poland </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Apr 13; Accepted 2025 Aug 18; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12371033  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40841424/" class="usa-link">40841424</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<p id="Par6">Doxorubicin (DOX) is widely used in treatment; however, its efficacy is often compromised by multidrug resistance (MDR), limiting therapeutic outcomes. This study investigates the anticancer potential of diosmetin (DT), a metabolite of diosmin commonly used in chronic venous insufficiency, and its ability to enhance the efficacy of DOX in the treatment of breast cancer. Several breast cancer cell lines were used to assess the effects of DT and DOX on cell viability. The MCF-7 cell line, which showed the most significant effect, was selected for further investigation. The effects of DT on apoptosis, DNA damage, and P-glycoprotein expression and activity were analyzed. DT significantly enhanced DOX-induced apoptosis and DNA damage, while downregulating ABCB1 expression and activity, a key factor in MDR development. These findings highlight the potential of DT as a valuable adjuvant in breast cancer therapy by enhancing the efficacy of DOX. Its ability to overcome multidrug resistance mechanisms underlines its potential for future clinical trials aimed at developing effective treatments.</p>
<section id="sec1"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1038/s41598-025-16681-3.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Diosmetin, Diosmin, Doxorubicin, DNA damage, <em>ABCB1</em> activity</p></section><section id="kwd-group2" class="kwd-group"><p><strong>Subject terms:</strong> Breast cancer, DNA damage and repair, Apoptosis</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p id="Par7">Breast cancer represents one of the most frequently diagnosed malignancies worldwide and is the primary cause of death among women<sup><a href="#CR1" class="usa-link" aria-describedby="CR1">1</a></sup>. Furthermore, Arnold et al. (2022) estimated an increase in newly diagnosed breast cancer incidence by more than 40% and a 50% increase in mortality by the year 2040<sup><a href="#CR2" class="usa-link" aria-describedby="CR2">2</a></sup>. Thus, breast cancer presents a significant healthcare and socioeconomic challenge.</p>
<p id="Par8">Doxorubicin (DOX) is a commonly prescribed anthracycline chemotherapeutic agent in the treatment of metastatic breast cancer<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a></sup>. However, DOX has a clinical efficacy rate of 40% due to the development of resistance during treatment<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a></sup>. The primary factor responsible for multidrug resistance (MDR) in cancer is the overexpression of several ATP-binding cassette (ABC) transporters located on the cell membrane. These proteins are linked to an energy-consuming pump to remove natural cellular metabolites or harmful chemicals from the cells. Overexpression of ATP-binding cassette transporters, particularly P-glycoprotein (P-gp), is a major contributor to MDR in breast cancer<sup><a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>,<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a></sup>. P-gp-ABCB1 reduces intracellular drug concentrations and mitigates their toxicity by facilitating the removal of anticancer drugs, including DOX, from cancer cells<sup><a href="#CR8" class="usa-link" aria-describedby="CR8">8</a></sup>. Suppression of ABC transporters could potentially overcome MDR and reverse the diminished anticancer properties of standard chemotherapeutic agents<sup><a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>–<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>.</p>
<p id="Par9">Naturally occurring dietary components, including flavonoids, have been found to effectively counteract MDR. Indeed, many flavonoids have been shown to suppress DOX resistance in tumor cells by blocking certain ABC transporters, enhancing the efficacy of DOX, preventing the emergence of MDR. In the group of flavonoids, diosmetin (DT) has been shown to have antitumor effects by controlling cell cycles, triggering apoptosis, and thus suppressing tumor growth in a variety of cancers<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup>. DT is the flavone aglycone and major metabolite of diosmin, a widely used drug for conditions related to venous insufficiency<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>,<a href="#CR11" class="usa-link" aria-describedby="CR11">11</a></sup>. When diosmin is administered, intestinal microflora enzymes hydrolyze it to DT and facilitate bloodstream absorption. Hence, DT constitutes the bioactive form of diosmin<sup><a href="#CR12" class="usa-link" aria-describedby="CR12">12</a></sup>. Furthermore, research indicates that DT itself, when administered directly, exhibits better bioavailability than diosmin. This is due to its smaller molecular size and higher lipophilicity, which allow for more efficient absorption without the need for metabolic conversion<sup><a href="#CR13" class="usa-link" aria-describedby="CR13">13</a></sup>. Chronic venous insufficiency is a common disease, especially in developing countries<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup>. It has been shown that breast cancer and chronic venous insufficiency appear to be strongly associated. Oncological treatment may predispose to a more severe clinical course of venous disease when present in patients with breast cancer<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>,<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a></sup>.This situation undoubtedly influences the popularity of preparations containing diosmin. The described properties of these substances suggest that the use of preparations that improve blood flow may be important in the prevention or treatment of many types of tumours. Because of the wide range of possible biological activities of this flavonoid, this effect is not obvious. It has not yet been established how the drugs commonly used to treat chronic venous insufficiency, which is also common in breast cancer patients, affect the development of breast cancer and chemotherapy, including DOX treatment.</p>
<p id="Par10">Therefore, the purpose of this study is to explore the impact of DT on breast cancer cells both as a monotherapy and in combination with DOX. The effects of DT on cell viability, apoptosis, and DNA damage were investigated. In addition, we examined its effect on ABC transporter expression and activity to better explain the observed interactions. The findings of this study are anticipated to provide a foundation for future research into the prospective application of DT as a viable co-chemotherapeutic agent in breast cancer therapy.</p></section><section id="Sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Cell culture and treatment</h3>
<p id="Par11">Four breast cancer lines (MCF-7, MDA-MB231, MDA-MB460, T47-D) were used in this study (ATCC, USA). The MCF-7 cells were cultured in Eagle’s minimum essential medium (EMEM) (Corning, USA), MDA-MB231, and MDA-MB460 were cultured in Kaighn’s Modification of Ham’s F-12 Medium (F12K) (Corning, USA), and T47D and ZR7 cell lines were cultured in RPMI (Corning, USA), supplemented with 10% fetal bovine serum (Corning, USA), and incubated at 37 °C with 5% CO2 in an air atmosphere.</p>
<p id="Par12">The cells were treated for 48 h with a range of DT concentrations(Sigma-Aldrich, USA) − 20, 40 and 80 µM and DOX (EBEWE Pharma, Austria) − 0.1, 0.5 and 1µM or a combination. In the control groups, cells were treated with DMSO (0.5%), which served as a vehicle for the treatment.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Cytotoxicity analysis</h3>
<p id="Par13">An MTT assay was performed to determine cell viability. The test relies on the ability of live cells to transform the orange tetrazolium salt (3-(4,5-dimethylthiazol-2-yl)−2,5-diphenyltetrazolium bromide) (Sigma-Aldrich, USA) into purple formazan crystals, which are insoluble in water. Hence, the quantity of formazan generated corresponds to the quantity of living cells. For all the assays, the cells were seeded into 96-well plates at a concentration of 2 × 10<sup>4</sup> cells per well. When 70–80% confluence was reached, the tested compounds were added. After a 48-hour incubation period, the prepared MTT solution (0.5 mg/mL in phosphate-buffered saline) was added to each well. Following a 4-hour incubation period, the MTT medium was discarded and the crystals formed were dissolved in DMSO. Control cultures were treated with DMSO (0.5%) as a vehicle. Quantification of the solution’s absorbance was conducted at 570 nm wavelength through the use of a PowerWave XS microplate spectrophotometer (BioTek Instruments, USA). Each assay was conducted three times and was evaluated in triplicate.</p></section><section id="Sec5"><h3 class="pmc_sec_title">Apoptosis detection</h3>
<p id="Par14">The evaluation of apoptosis was conducted employing the NucleoCounter NC-3000 (ChemoMetec, Denmark) and Annexin V Apoptosis Assay (ChemoMetec, Denmark). The cells were seeded into 6-well plates at a concentration of 4 × 10<sup>5</sup> cells/well, and the tested compounds were added when 70–80% of confluence was achieved. Following 48 h of incubation with the examined substances, the cells were harvested using trypsin-EDTA solution (Corning, USA), and stained with Annexin V-FITC (fluorescein isothiocyanate), Hoechst 33,342, and propidium iodide by the manufacturer’s recommended protocol. The cell suspension (6 × 10<sup>4</sup>/30µl) was loaded into the NC-Slide and read in the NucleoCounter NC-3000. The gating strategy was established based on forward and side scatter properties to exclude debris, followed by quadrant analysis on FITC and PI fluorescence to identify distinct cell populations. Unstained and single-stained controls were used to set compensation and define the gates accurately. This approach allowed precise quantification of apoptosis across experimental groups. Each experiment was conducted in triplicate, with three independent repetitions, following the previously established methodology<sup><a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>,<a href="#CR17" class="usa-link" aria-describedby="CR17">17</a></sup>.</p></section><section id="Sec6"><h3 class="pmc_sec_title">Comet assay</h3>
<p id="Par15">This approach is utilized to identify the genotoxic substances. MCF-7 cells were seeded as above (in 6-well plates at a concentration of 1 × 10<sup>5</sup> cells/well) and treated with DOX (1 µM), and DT (80 µM) and their combination of both for 48 h. The cells were collected by trypsinization using a trypsin–EDTA solution (Corning, USA), and washed with PBS. Each sample’s final concentration of MCF-7 cells was adjusted to 1 × 10<sup>5</sup>. The comet assay was conducted under neutral conditions (pH 8.5), as described previously by Olive et al., 2006<sup><a href="#CR18" class="usa-link" aria-describedby="CR18">18</a></sup>. The cell suspensions (0.4 mL) were mixed with 1.2mL of 1% (w/v) low melting point agarose (LMA), and then distributed onto microscope slides coated with 1% (w/v) normal melting agarose, covered with a cover slip, and kept for 10 min at 4 °C to solidify. Then, the microscope slides were submerged in a covered dish containing N1 lysis solution (2% sarkosyl, 0.5 M Na<sub>2</sub>EDTA, 0.5 mg/ml proteinase K (pH 8.0) (ThermoFisher, USA) and kept at 37 °C overnight in the dark. After overnight lysis, the slides were two times submerged in room temperature N2 rinse buffer (90 mM Tris buffer, 90 mM boric acid, 2 mM Na2EDTA (pH 8.5)) for 30 min and placed in an electrophoresis tank horizontally side by side. Electrophoresis in solution N2 was run for 25 min at 0.6 V/cm. After electrophoresis, the slides were washed for 15 min in distilled water, and stained using Hoechst 33342 (5 µg/mL) for another 20 min and excess stained slides were rinsed with 400 ml of distilled water Comet images were captured using a Nikon Eclipse Ti inverted microscope with NIS-Elements Imaging Software (Nikon, Japan). One hundred individual cells were selected for calculations for each analysis. The slides were examined under a fluorescence microscope with a filter that matched the previously applied fluorescent dye. The images were analyzed using OpenComet (v1.3) a plugin for the image processing program ImageJ<sup><a href="#CR19" class="usa-link" aria-describedby="CR19">19</a></sup> which gives % DNA in tail, tail length, and tail moment (TM), directly. The parameter TM is the product of tail length and % DNA in the tail. The software determines the fluorescence intensity by calculating many factors that describe the extent of DNA damage in each cell. The proportion of DNA in the comet’s “head” represents genetic material in the nucleus, while the fluorescent area in the “tail” indicates genetic material that has moved out of the cell nucleus during electrophoresis. Tail length, and Olive moment were used as evaluations of the DNA damage.</p></section><section id="Sec7"><h3 class="pmc_sec_title">Molecular docking simulations</h3>
<p id="Par16">To explore the interaction between DT and the P-gp receptor, molecular docking technology was used. Specifically, AutoDock 4.2 molecular docking software was applied for semi-flexible docking between DT and P-gp in this study. Semi-flexible docking means that the receptor is rigid, while the ligand structure may change within a certain range. The docking model was performed based on the 3D crystal structures of human P-glycoprotein and was downloaded from the Protein Data Bank (PDB) (PDB code: 6C0V). Ligands and proteins were pre-paired using a previously established approach<sup><a href="#CR20" class="usa-link" aria-describedby="CR20">20</a></sup>. The preparation of the selected protein involved removing water molecules and all co-crystallized entities from the protein structures. Additionally, polar hydrogen atoms were added to the enzyme structures, nonpolar hydrogen atoms were merged, and Kollman charges were assigned and distributed over the residues. All preparation procedures were performed using AutoDock Tools v.1.5.7<sup><a href="#CR21" class="usa-link" aria-describedby="CR21">21</a></sup>. The docking parameters are given in Table <a href="#Tab1" class="usa-link">1</a>.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Molecular Docking parameters. AutoDock 4.2 molecular Docking software was used for semi-flexible Docking between DT and P-gp. The tested protein was treated as rigid while keeping the ligand flexible. P-gp: P-glycoprotein; DT- diosmetin.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Size of girid box</th>
<th align="left" colspan="1" rowspan="1">100 × 100 × 100</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Girid points spaced</td>
<td align="left" colspan="1" rowspan="1">0.375</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Algorithm</td>
<td align="left" colspan="1" rowspan="1">Lamarckian genetic algorithm (LGA)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Genetic algorithm runs</td>
<td align="left" colspan="1" rowspan="1">30</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Population size</td>
<td align="left" colspan="1" rowspan="1">300 inviduals</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Maximum numer of Energy evaluations</td>
<td align="left" colspan="1" rowspan="1">250,000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Gegenerations</td>
<td align="left" colspan="1" rowspan="1">150,000</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Mutation rate</td>
<td align="left" colspan="1" rowspan="1">0.02</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Crossover rate</td>
<td align="left" colspan="1" rowspan="1">0.80</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p id="Par18">The conformations with the lowest binding energies were chosen for comparison with the docking results of the reference ligands. Positions with a root mean square deviation (RMSD value (≤ 2.0) confirm the relevant predictions for the compounds of interest<sup><a href="#CR22" class="usa-link" aria-describedby="CR22">22</a></sup>. We obtained 0,936 Å, which indicated that the parameters in the docking simulations were acceptable (Fig. <a href="#Fig4" class="usa-link">4</a>c). Discovery Studio Visualizer v.21.1. was used for visualization and interpretation of the received data<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>. To validate the docking protocol and provide a comparative basis, known P-gp inhibitor verapamil was docked to the same P-gp structure (PDB ID: 6C0V) as reference compounds<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a></sup>. The docking results of DT were compared to these controls based on binding energy and estimated inhibition constants (Ki). These comparisons help contextualize DT’s predicted inhibitory potential.</p>
<figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371033_41598_2025_16681_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/12371033/2e95e227678f/41598_2025_16681_Fig4_HTML.jpg" loading="lazy" id="d33e726" height="344" width="669" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>a</strong>) 2D scheme of the P-gp complex with DT, (<strong>b</strong>) Binding energy values obtained during docking analysis of DT with P-gp. Verapamil, standard reference P-gp inhibitor was selected as the control ligands, (<strong>c</strong>) Overlying of ligands. Overlying of real (yellow-colored) and predicted position (pink-colored) of the ligand DT (RMSD = 0.936) P-gp (PDB code: 6C0V), (<strong>d</strong>) 3D representation of diosmetin (DT) docked in the binding cavity of P-glycoprotein (P-gp, PDB: 6C0V). Hydrogen bonds (dashed yellow lines) and hydrophobic interactions with key residues are indicated. Visualization performed using Discovery Studio Visualizer<sup><a href="#CR23" class="usa-link" aria-describedby="CR23">23</a></sup>.</p></figcaption></figure></section><section id="Sec8"><h3 class="pmc_sec_title">Hoechst accumulation assay</h3>
<p id="Par19">The cells were seeded into 6-well plates at a concentration of 4 × 10<sup>5</sup> cells/well, and the tested compounds were added when 70–80% of confluence was achieved. To measure the activity of of P-gp in the tested MCF-7 cells Hoechst Accumulation Assay was performed using the Hoechst 33,342 (5 µg/mL) which is a fluorogenic dye. After 48 h of incubation with the tested substances, the cells were stained with Hoechst 33,342 (ThermoFisher, USA) Subsequently, the cells were subjected to incubation at 37 °C for 30 min. Following the incubation, the cells were washed three times with PBS and were then visualized using a fluorescence microscope on a Nikon Eclipse Ti inverted microscope with NIS-Elements Imaging software NIS-Elements BR, version 3.22 (Nikon, Japan, <a href="https://www.microscope.healthcare.nikon.com/products/software/nis-elements" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.microscope.healthcare.nikon.com/products/software/nis-elements</a>). For each sample, 3 random fields of view were selected using a 20× objective lens. In each field of view, 20 nuclei were analyzed, ensuring that the nuclei were clearly stained, non-overlapping, and fully visible within the analyzed area. Nuclei with atypical morphology (e.g., fragmented or unevenly stained) were excluded from the analysis. Regions of Interest (ROI) corresponding to the nuclei were automatically defined using the software’s thresholding and segmentation tools, optimized for the Hoechst 33,342 fluorescence channel. For each automatically defined ROI, the mean fluorescence intensity (Mean Intensity) was measured in the channel corresponding to Hoechst 33,342 emission. The procedure was repeated for 3 biological replicates, with each field of view analyzed independently. In total, the fluorescence intensity of 60 nuclei per sample (3 fields of view × 20 nuclei) was measured. The recorded mean fluorescence intensity values were saved for further statistical analysis.</p></section><section id="Sec9"><h3 class="pmc_sec_title">The quantitative real-time PCR analysis (qRT-PCR)</h3>
<p id="Par20">The cells were seeded into a 25-cm<sup>3</sup> flask at a concentration of 4 × 10<sup>4</sup> cells/mL. The tested compounds were added when 70–80% of confluence was achieved. After 48 h of incubation, 1 mL of TRIzol™ Reagent (Invitrogen, USA) was added to the culture dish to lyse the cells. Afterward, the lysate was centrifuged for 5 min at 12,000× g at 4 °C, and then the clear supernatant was treated in compliance with the producent’s protocol. The obtained RNA was quantified and normalized to equal concentrations prior to reverse transcription, which was performed using the NG dART RT-PCR kit (EURx, Poland) in accordance with the manufacturer’s instructions. The qPCR was performed using SG/ROX qPCR Master Mix reagents (2x) (EURx, Poland) based on the manufacturer’s instructions in a 7500 Fast Real-Time PCR System (ThermoFisher, USA). The reaction was conducted in triplicate. The procedure was repeated for 3 biological replicates. The relative expression of the tested genes was performed by qRT-PCR and the ΔΔCt method using <em>18SRNA</em> and <em>ACTB</em> as reference genes. A statistical analysis was determined with RQ values (relative quantification, RQ = 2<sup>−∆ΔCt</sup>). The primer sequences are summarized in Table <a href="#Tab2" class="usa-link">2</a>.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Primers used in the assessment of gene expression.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Target</th>
<th align="left" colspan="1" rowspan="1">Forward Sequence (5′→3′)</th>
<th align="left" colspan="1" rowspan="1">Reverse Sequence (3′→5′)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong><em>ABCB1</em></strong>
</td>
<td align="left" colspan="1" rowspan="1">TCTTCACCTCCAGGCTCAGT</td>
<td align="left" colspan="1" rowspan="1">GCTCCTGACTATGCCAAAGC</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong><em>18SN5</em></strong>
</td>
<td align="left" colspan="1" rowspan="1">GCAGAATCCACGCCAGTACAAG</td>
<td align="left" colspan="1" rowspan="1">GCTTGTTGTCCAGACCATTGGC</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">
<strong><em>ACTB</em></strong>
</td>
<td align="left" colspan="1" rowspan="1">CACCATTGGCAATGAGCGGTTC</td>
<td align="left" colspan="1" rowspan="1">AGGTCTTTGCGGATGTCCACGT</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section></section><section id="Sec10"><h3 class="pmc_sec_title">Analysis of P-glycoprotein expression by western blotting</h3>
<p id="Par22">The cells were seeded into a 25-cm<sup>3</sup> flask at a concentration of 4 × 10<sup>4</sup> cells/mL. The tested compounds were added when 70–80% of confluence was achieved. After 48 h, the cells were washed twice with cold PBS. Next, 1 ml of cold RIPA buffer (ThermoFisher, USA) was added to the cells and the protein was isolated according to the manufacturer’s instructions. the protein concentration in the supernatants was determined by the Bradford method. The extracted protein (20 µg) was loaded in a polyacrylamide gel (NuPAGE Bis-Tris Gels, Invitrogen, USA) and 50-min electrophoretic separation was performed under reducing conditions with XCellSureLock instrument (Invitrogen, USA) at a constant voltage of 200 V. After separation, the gel and the nitrocellulose membrane (Invitrogen, USA) were placed between two layers of the filter paper and put between two electrodes of the XCell II Blot Module electrotransfer apparatus (Invitrogen, USA). The transfer was conducted for 60 min at a constant voltage of 30 V. Blots were developed using Western Breeze Chromogenic Detection Kit (Invitrogen, USA). For simultaneous detection of different primary antibodies, membranes were carefully cut horizontally before antibody incubation. Nonspecific antibody-binding sites were blocked and the membrane was incubated in the solution of the primary antibody: P-Glycoprotein Polyclonal Antibody (PA5-87086, ThermoFisher, USA) or β-actin antibody (N-21) (Santa Cruz Biotechnology, USA). After washing, the membrane was incubated with the secondary antibody combined with alkaline phosphatase. The last step was to mark the sites of reaction with antigen by the reaction of alkaline phosphatase and chromogen. Band intensities were quantified by densitometric analysis with the Image Studio 6.0 Software (Li-Cor, USA) and normalized to β-actin as a loading control. Before analysis, the blot images were converted to grayscale. Values were expressed as the ratio of target protein to β-actin band intensity.</p></section><section id="Sec11"><h3 class="pmc_sec_title">Statistical analysis</h3>
<p id="Par23">The statistical analysis was performed using the STATISTICA 13 software (StatSoft, Poland). The normality of the variable distribution was verified using the Shapiro–Wilk test. The data were analyzed using Two-way analysis of variance (ANOVA) with DOX and DT80 treatments (presence/absence) as fixed factors. The model also included the interaction term between both treatments. Post-hoc multiple comparisons were conducted using Tukey’s honest significant difference test. The correlation between tail length and tail moment in the comet assay was assessed using Pearson’s correlation coefficient. Results were reported as mean ± standard deviation (SD) and statistical significance was defined at <em>p</em> &lt; 0.05. All experiments were performed in three independent biological replicates, each including s technical replicates.</p>
<p id="Par24">Synergy analysis of DOX and DT was performed using Combenefit (Cancer Research UK Cambridge Institute). The percent inhibition values were used to construct an effect matrix which was analysed using the Highest Single Agent (HSA) model. This model assumes that the effect of the combination should not exceed that of the more potent drug in the combination. Heat maps of drug-drug interactions and quantitative synergy indices were obtained to assess the nature and strength of the interaction of the compounds studied<sup><a href="#CR25" class="usa-link" aria-describedby="CR25">25</a></sup>.</p></section></section><section id="Sec12"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec13"><h3 class="pmc_sec_title">Cytotoxicity analysis</h3>
<p id="Par25">The results of the MTT assay showed that DT reduced cell viability in all cell lines tested, but only in the case of MCF7 an IC<sub>50</sub> value (69.2 µM) was reached (Fig. <a href="#Fig1" class="usa-link">1</a>a). Synergy analysis of DOX and DT was performed using Combenefit. The percent inhibition values were used to construct an effect matrix which was analysed using the Highest Single Agent (HSA) model (Fig. <a href="#Fig1" class="usa-link">1</a>B). This model assumes that the effect of the combination should not exceed that of the more potent drug in the combination. Heat maps of drug-drug interactions and quantitative synergy indices were obtained to assess the nature and strength of the interaction of the compounds studied.</p>
<figure class="fig xbox font-sm" id="Fig1"><h4 class="obj_head">Fig. 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371033_41598_2025_16681_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/12371033/7a91f75bf71e/41598_2025_16681_Fig1_HTML.jpg" loading="lazy" id="d33e598" height="1182" width="658" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>a</strong>) Cytotoxicity of DOX (0.1–1.0 µM), DT (20–80 µM) or combined, based on MTT test results after 48 h of incubation. Control cultures were treated with DMSO (0.5%) as a vehicle. The data derived from three independent experiments were reported as the mean ± SD. (<strong>b</strong>) Heat maps of drug-drug interactions analysed using the Highest Single Agent (HSA) model, numerical synergy scores (mean ± SD) are shown within each cell of the heatmaps (negative scores indicate antagonism, positive values indicate synergy), (*//*) z-score level that indicates a significance of the deviation of the observed effect from the expected value according to the HSA model.</p></figcaption></figure><p id="Par26">The results of the synergy analysis of DOX and DT using the HSA model showed a clear synergistic interaction at several dose combination points for all lines tested. The highest synergy values were observed for combinations of medium and high concentrations of DOX (0.5 and 1.0 µM) with higher concentrations of DT (40 and 80 µM). The highest synergy score was shown for the MCF7 cell line (19 vs. 17 for MDA-MB-458, 16 for MDA-MB-231 and 10 for T47D, Fig. <a href="#Fig1" class="usa-link">1</a>b). Based on the results of the MTT assays, 80 µM DT, 1 µM DOX, and their combination demonstrated the strongest cytotoxic effects on the MCF-7 cell line and were thus selected for further studies. DOX at 1 µM was selected based on its submaximal cytotoxic effect (IC50 = 0.92µM) ensuring that the observed enhancement by DT reflects true potentiation, not merely additive cytotoxicity. Accordingly, the MCF-7 cell line was chosen for an in-depth analysis of the mechanisms of action of these compounds.</p></section><section id="Sec14"><h3 class="pmc_sec_title">Apoptosis detection</h3>
<p id="Par28">Detection of apoptosis by imaging cytometry showed that after 48-hour incubation with DT, populations of early and late-apoptotic cells were present (30.33 ± 6.11and 18.67 ± 2.88%, respectively). A similar distribution of apoptotic cells was observed in cultures treated with DOX(31.00 ± 2.00% early and 17.67 ± 2.08% late apoptotic cells). The combination of tested compounds significantly increased both populations of apoptotic cells – early apoptotic to 61.33 ± 8.32 and late apoptotic cells to 32.34 ± 3.78%. Necrotic fractions were consistently low in all cultures (Annexin⁻/PI⁺): control 1.67 ± 0.52%, DOX 1.0 ± 0.89%, DT 2.0 ± 0.89%, DT + DOX 1.67 ± 1.86%, suggesting that the cytotoxicity observed is primarily apoptotic cannot be attributed to non-specific membrane damage (Fig. <a href="#Fig2" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371033_41598_2025_16681_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/12371033/7085ffc0c882/41598_2025_16681_Fig2_HTML.jpg" loading="lazy" id="d33e628" height="325" width="669" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Apoptosis/necrosis detection by image cytometry. MCF-7 cells were treated with 1 µM DOX or 80 µM DT and combined, after 48 h incubation. Control cultures were treated with DMSO (0.5%) as a vehicle <strong>a</strong>. Representative histograms of three independently performed. Q1II—live, Q1Ir—early apoptotic, Q1ur—late apoptotic, and Q1uI—necrotic cells. <strong>b</strong>. The data derived from three independent experiments reported as the mean ± SD. DOX: doxorubicin; DT: diosmetin; DT + DOX: diosmetin + doxorubicin. <em>p</em> &lt; 0.05 vs. control, ^<em>p</em> &lt; 0.05 vs. DOX alone.</p></figcaption></figure></section><section id="Sec15"><h3 class="pmc_sec_title">Comet assay</h3>
<p id="Par30">The neutral comet assay is a reliable and accurate sensitive tool for the identification and quantitation of double-strand DNA breaks (DSBs) at the single-cell level. The neutral comet assay specifically detects DSBs because it preserves the integrity of double-stranded DNA during lysis and electrophoresis. Unlike alkaline comet assays, which can also detect single-strand breaks (SSBs) but may not differentiate them from DSBs, the neutral conditions prevent the denaturation of DNA, allowing for a clearer assessment of double-strand integrity<sup><a href="#CR26" class="usa-link" aria-describedby="CR26">26</a></sup>.</p>
<p id="Par31">DOX treatment as well as DT alone led to DNA damage in MCF-7 cells, as evidenced by the significant increase in the comet parameter (tail length, tail moment) as compared to the control group. Co-administration of DT along with DOX, significantly elevated DOX-induced DNA damage (Fig. <a href="#Fig3" class="usa-link">3</a>). To confirm consistency between the two sets of readings, we assessed the correlation between tail length and tail moment in all samples. A strong positive correlation was observed (Pearson’s <em>r</em> = 0.89, <em>p</em> &lt; 0.001), which confirms that both parameters accurately reflect DSB accumulation in this study.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/12371033/4c210920d213/41598_2025_16681_Fig3_HTML.jpg" loading="lazy" id="d33e677" height="1575" width="747" alt="Fig. 3"></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>DNA damage induced by DT, DOX and both simultaneously detected by the neutral comet assay in MCF-7 cells. (<strong>a</strong>) Representative micrographs of comet assay results. MCF-7 cells were treated with 1 µM DOX or 80 µM DT and combined for 48 h, control cultures were treated with DMSO (0.5%) as a vehicle (acquired at 100x and 200x magnification). (<strong>b</strong>) Representative graph obtained by plotting the means of tail length and tail moment (<strong>c</strong>). The values are presented as the mean of three independent experiments ± SD. 100 individual cells were selected for calculations. <em>DOX</em> doxorubicin, <em>DT</em> diosmetin,<em>DT + DOX</em> diosmetin + doxorubicin.</p></figcaption></figure></section><section id="Sec16"><h3 class="pmc_sec_title">Molecular docking results</h3>
<p id="Par33">DT’s bioactive conformations and their selectivity for the P-gp transporter, which are viable targets for reducing MDR in DOX therapy, were evaluated by employing molecular docking to determine the docking scores of the interaction between DT and P-gp.</p>
<p id="Par34">The results of the docking study are displayed in terms of binding energies and Estimated Inhibition Constant, Ki. out of 30 docking modes analyzed by LGA cluster analysis, the mode with the lowest energy and its respective Ki prediction was chosen for each docking DT and exhibited favorable in silico simulations results with a value of binding energy − 8.65 kcal/mol and inhibition constant 454.73 nM (Fig. <a href="#Fig4" class="usa-link">4</a>b). RMSD of re-docked native ligand = 0.936 Å, confirming docking accuracy (Fig. <a href="#Fig4" class="usa-link">4</a>c). Verapamil, a well-known P-gp inhibitor, was selected as the control ligands. It was observed that DT exhibited appropriate affinity (−8,65 kcal/mol) to drug binding pocket of P-gp when compared with verapamil that showed binding affinities of −6.48 kcal/mol (Figure Xb). Molecular docking simulations using AutoDock 4.2 revealed that DT exhibited strong binding affinity to P-gp (binding energy: −8.65 kcal/mol), forming hydrogen bonds with VAL168, ASP167, and THR1174 (Fig. <a href="#Fig4" class="usa-link">4</a>a). These interactions suggest stable complex formation and support DT’s role as a potential P-gp inhibitor. The 3D visual binding model of DT in the active cavity of P-gp is shown in Fig. <a href="#Fig4" class="usa-link">4</a>d.</p>
<p id="Par35">Molecular docking was implemented for DT to gain a thorough insight into the prospective paths of action to improve DOX chemotherapy efficacy by strongly suppressing the P-gp transporter Hence, it may be assumed, that the properties of DT associated with enhanced DOX cytotoxicity are probably related to the activity of P-gp proteins.</p>
<p id="Par36">The results from the in silico docking simulations suggest that DT is a promising base for the exploration of new molecules targeting P-gp as potent anticancer agents. These results provide a research basis for our hypothesis, and we performed in vitro experiments to validate specific mechanisms of DT.</p></section><section id="Sec17"><h3 class="pmc_sec_title">Hoechst accumulation assay</h3>
<p id="Par38">In the Hoechst Accumulation Assay, the weakest fluorescence signal was observed in the group of cells treated with DOX (21.90 ± 3.65 vs. 70.04 ± 13.17 RFU/cell in control cells, Fig. <a href="#Fig5" class="usa-link">5</a>b), which may indicate high P-gp activity in MCF-7 line cells treated with the chemotherapeutic agent. However, DT administration led to a notable rise in intracellular fluorescence compared to very faint signals derived from DOX treated group (64.28 ± 13.19 RFU/cell). The obtained images were similar to those that were obtained from the control group (Fig. <a href="#Fig5" class="usa-link">5</a>). A strong fluorescence signal after simultaneous administration of DT and DOX suggests that the tested flavonoid inhibits the enhanced P-gp activity caused by the administration of DOX.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371033_41598_2025_16681_Fig5_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/12371033/4a3f1a5cf955/41598_2025_16681_Fig5_HTML.jpg" loading="lazy" id="d33e759" height="1182" width="782" alt="Fig. 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Evaluation of P-glycoprotein (P-gp) activity in MCF-7 cells using Hoechst Accumulation Assay. (<strong>a</strong>) Representative micrographs of cells stained with Hoechst33342. MCF-7 cells were treated with 1 µM DOX or 80 µM DT and combined for 48 h. Control cultures were treated with DMSO (0.5%) as a vehicle (acquired at 200x magnification) (<strong>b</strong>) The intensity of fluorescence, measured by Nikon Eclipse Ti inverted fluorescence microscope. For each sample, three random fields of view were selected, and in each field, 20 nuclei were analyzed. The values are presented as the mean of three independent experiments ± SD. DOX: doxorubicin; DT: diosmetin; DT + DOX: diosmetin + doxorubicin. <em>p</em> &lt; 0.05 vs. control, ^<em>p</em> &lt; 0.05 vs. DOX alone.</p></figcaption></figure></section><section id="Sec18"><h3 class="pmc_sec_title">Expression <em>of ABCB1</em>/P-gp at the mRNA and protein levels</h3>
<p id="Par40">mRNA expression analysis showed a more than 12-fold increase in mRNA expression for <em>ABCB1</em> after incubation of MCF-7 cells with DOX. In contrast, DT decreased the expression of this gene to a level of approximately 25% of control. Co-incubation of cells with DOX and DT resulted in a more than 4-fold decrease in expression compared to the effect of DOX alone (Fig. <a href="#Fig6" class="usa-link">6</a>a). Analysis of P-gp expression (normalized to B-akt) revealed low levels of this protein in control cells, with a significant increase observed after incubation with DOX. As with mRNA levels, DT reduced the level of the protein under study, both when used alone and in combination with DOX (Fig. <a href="#Fig6" class="usa-link">6</a>b). The data obtained indicate that the regulation of P-gp expression under experimental conditions occurs primarily at the transcription level.</p>
<figure class="fig xbox font-sm" id="Fig6"><h4 class="obj_head">Fig. 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12371033_41598_2025_16681_Fig6_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4840/12371033/3f3103d6256a/41598_2025_16681_Fig6_HTML.jpg" loading="lazy" id="d33e815" height="1182" width="754" alt="Fig. 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig6/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(<strong>a</strong>) Relative mRNA expression level of <em>ABCB1</em>. The results were calculated as RQ values and presented as the mean ± SD values of three independent experiments. <em>ACTB</em> and <em>18SN5</em> were used as reference genes. (<strong>b</strong>) Relative expression level of P-gp protein normalized to β-actin. (<strong>c</strong>) Representative western blot (cropped for clarity). Original blots are presented in Supplementary Fig. <a href="#Fig1" class="usa-link">1</a>S. Control cultures were treated with DMSO (0.5%) as a vehicle The cells were treated for 48 h with 1 µM of doxorubicin (DOX) and 80 µM of diosmetin (DT), or combined (DT + DOX). <em>p</em> &lt; 0.05 vs. control, ^<em>p</em> &lt; 0.05 vs. DOX alone.</p></figcaption></figure></section></section><section id="Sec19"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par42">DOX, as an anthracycline antibiotic, has been widely recognized for its efficacy in breast cancer treatment due to its mechanisms of action, which include DNA intercalation and the generation of free radicals<sup><a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>,<a href="#CR28" class="usa-link" aria-describedby="CR28">28</a></sup>. Despite its effectiveness, the clinical application of DOX is limited by its side effects, such as cardiotoxicity, and the development of drug resistance, which significantly diminishes its therapeutic potential<sup><a href="#CR29" class="usa-link" aria-describedby="CR29">29</a>,<a href="#CR30" class="usa-link" aria-describedby="CR30">30</a></sup>. Therefore, enhancing the sensitivity of breast cancer cells to DOX may lead to more effective treatment regimens.</p>
<p id="Par43">Among the natural compounds with beneficial effects on human health, DT has attracted considerable interest because of its potent antioxidant<sup><a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>,<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a></sup> and anti-inflammatory<sup><a href="#CR33" class="usa-link" aria-describedby="CR33">33</a></sup> properties, as well as its ability to inhibit cancer growth. The described properties of these substances suggest that the use of preparations that improve circulation may have a role in the prevention of various types of cancer. Previous studies have revealed that DT exhibits antitumor properties through the suppression of cell proliferation, activation of cell apoptosis, and regulation of the cell cycle in various cancer cell types, including breast cancer, liver cancer, colon cancer, leukemia, and other tumor cells<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>–<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a></sup> Unlike other flavonoids primarily studied in vitro, DT is already routinely administered in therapeutic settings in chronic venous insufficiency where it affects approximately 30–40% of adults<sup><a href="#CR10" class="usa-link" aria-describedby="CR10">10</a></sup>. Undoubtedly, this state of affairs, relatively low price and intensive advertising has an impact on the popularity of preparations containing diosmin. Chronic venous disease often co-exists with breast cancer. The presence of breast cancer was linked to simultaneous chronic venous clinical symptoms in patients with positive estrogen receptor status<sup><a href="#CR14" class="usa-link" aria-describedby="CR14">14</a></sup>.Therefore, it is presumed that patients with this oncological disease can often support their treatment with readily available diosmin preparations. So far, it has not been demonstrated what effect preparations commonly used in chronic venous insufficiency have on the development of breast cancer. Based on these findings, DT has emerged as a promising therapeutic candidate for cancer treatment.</p>
<p id="Par44">The study investigated the effects of DT and DOX on breast cancer cells, demonstrating that this flavonoid substantially enhances the anticancer activity of DOX. Notably, treatment with 80 µM DT and 1 µM DOX significantly reduced MCF-7 cell viability, indicating increased cytotoxicity compared to DOX alone. Although the in vitro concentration of 80 µM used in our study is considerably higher than the concentrations of free diosmetin typically found in human plasma following diosmin intake<sup><a href="#CR34" class="usa-link" aria-describedby="CR34">34</a></sup> this discrepancy can be explained by diosmetin’s metabolism in vivo. Like most flavonoids, diosmetin undergoes extensive first-pass metabolism, resulting mainly in glucuronide conjugates, such as diosmetin-3-O-glucuronide, that circulate in plasma<sup><a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>,<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a></sup>. Consequently, the concentration of free (aglycone) diosmetin in serum is generally low. However, increased β-glucuronidase activity in the tumour microenvironment can locally cleave these conjugates, regenerating the active aglycone form and thereby elevating diosmetin concentrations specifically within tumour tissue<sup><a href="#CR37" class="usa-link" aria-describedby="CR37">37</a></sup>. This tumour-selective enzymatic hydrolysis process supports the translational relevance of our findings, suggesting that pharmacologically effective diosmetin concentrations can be achieved locally despite low systemic aglycone levels.</p>
<p id="Par45">DT increases the percentage of apoptotic cells compared to cells treated with DOX alone Our results also showed that DT induces DNA double-strand breaks and significantly increases DOX-induced DNA damage, as confirmed by comet assay. Molecular docking studies suggested that DT may interact favorably with P-gp, potentially offering a strategy to address multidrug resistance. These findings underscore the potential of DT as a sensitizing agent in DOX-based chemotherapy regimens.</p>
<p id="Par46">These results suggest that DT holds potential as an adjunctive agent requiring further preclinical and in vivo validation. The current study sought to determine DT’s impact alone and in combination with DOX on the proliferation of human breast cancer cells. The cytotoxicity assay proved that DT decreased the growth of all examined breast cancer cell lines, particularly the most significant effect was observed in MCF-7 cells (Fig. <a href="#Fig1" class="usa-link">1</a>a). The proven high anti-proliferative capabilities are consistent with previous research that has shown that the growth of breast cancer is substantially suppressed by DT<sup><a href="#CR3" class="usa-link" aria-describedby="CR3">3</a>,<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a></sup>. Additionally, this study explored the effect of DT on DOX cytotoxicity in breast cancer cells. Based on the MTT assay, we found that DT significantly increased the cytotoxicity of DOX in all analyzed breast cancer cell lines. The strongest effect was also observed in MCF-7 cells (Fig. <a href="#Fig1" class="usa-link">1</a>b).</p>
<p id="Par47">Moreover, DT has demonstrated promising anticancer properties with a favorable safety profile. Multiple studies have shown that DT selectively inhibits the proliferation of various cancer cell lines, while exerting minimal cytotoxic effects on corresponding normal cells such as mammary epithelial cells, lung epithelial cells, and colon epithelial cells. These findings underscore the potential of DT as a selective anticancer agent that minimizes damage to healthy tissue, thereby positioning it as a promising candidate for further investigation in cancer therapeutics<sup><a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>,<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>,<a href="#CR39" class="usa-link" aria-describedby="CR39">39</a></sup>.</p>
<p id="Par48">Previous research has demonstrated that DT effectively collaborates with anticancer medications in different cancer cell types. According to research, the simultaneous use of 5-FU and DT has a beneficial effect on inhibiting the proliferation of HCT116 cancer cells. This co-administration has the potential to mitigate the negative side effects of 5-FU while increasing its effectiveness against cancer by triggering apoptosis<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a></sup>. Moreover, it has been shown that through the reduced activity of Nrf2 and inhibition of the PI3K/Akt/GSK-3 pathway, the simultaneous administration of DT and paclitaxel effectively caused cell death in non-small cell lung cancer cells<sup><a href="#CR41" class="usa-link" aria-describedby="CR41">41</a></sup>.</p>
<p id="Par49">The comet assay results confirmed the presence of DNA damage after DT treatment. This is consistent with previous studies where DT caused DNA damage in cells of various cancers<sup><a href="#CR42" class="usa-link" aria-describedby="CR42">42</a>,<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a></sup>. They indicated that DT not only induced DNA damage itself but also significantly enhanced the damage caused by DOX treatment, resulting in the longest comet tails in MCF-7 cells (Fig. <a href="#Fig3" class="usa-link">3</a>). These findings confirm that DT can exacerbate DNA damage in cancer cells while amplifying the effects of DOX. It may be inferred that the accumulation of DNA strand breaks ultimately leads to apoptosis, and therefore, the increased cytotoxicity observed with the combined treatment of DOX and DT likely originates from this enhanced generation of DNA damage.</p>
<p id="Par50">Interestingly, <em>in sillico</em> study revealed a possible interaction between DT and P-gp. P-glycoprotein (P-gp), encoded by the ABCB1 gene, is a well-known efflux pump that significantly contributes to MDR. Several studies have highlighted the significance of P-gp in mediating chemoresistance in various types of cancers. Specifically, increased expression has been noted in numerous malignancies, including breast cancer<sup><a href="#CR44" class="usa-link" aria-describedby="CR44">44</a></sup>. The protective function of ABCB1 against the cytotoxic effects of chemotherapeutic drugs has been demonstrated in several cell lines, including MCF-7<sup><a href="#CR45" class="usa-link" aria-describedby="CR45">45</a></sup>. The mechanisms underlying P-gp-mediated chemoresistance involve the active efflux of anticancer agents from malignant cells, resulting in reduced intracellular levels of medications and diminished drug efficacy<sup><a href="#CR46" class="usa-link" aria-describedby="CR46">46</a></sup>. Upregulation of ABC transporters can result in resistance to traditional chemotherapeutics, including DOX<sup><a href="#CR47" class="usa-link" aria-describedby="CR47">47</a></sup>.</p>
<p id="Par51">It has been shown that DOX can activate glycoprotein-p in cancer cells<sup><a href="#CR48" class="usa-link" aria-describedby="CR48">48</a></sup>. In our study, a significant increase in mRNA and protein expression as well as glycoprotein-p activity was observed after incubation of breast cancer cells with DOX. Thus, inhibiting drug transport or manipulating its expression in cancer cells represents a potent strategy to counteract MDR in cancer. Flavonoids have been identified as potent P-gp inhibitors capable of reversing MDR in cancer cells by binding to transporters and disrupting drug efflux<sup><a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>,<a href="#CR49" class="usa-link" aria-describedby="CR49">49</a></sup>. Further research has demonstrated that DT and similar compounds can counteract MDR, thereby enhancing the efficacy of chemotherapeutic agents<sup><a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>,<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>,<a href="#CR50" class="usa-link" aria-describedby="CR50">50</a></sup>. However, specific pathways of how DT affects ABC transporters remain unclear.</p>
<p id="Par52">To confirm our initial in silico study, we performed a Hoechst 33,342 accumulation assay to assess P-gp activity in the examined cells. According to previous study High P-gp activity leads to lower levels of H342 accumulation. Consequently, H342 can be effective in identifying cells resistant to multiple drugs because it possesses qualities typical of P-gp substrates and is particularly suited to recognizing elevated resistance levels<sup><a href="#CR51" class="usa-link" aria-describedby="CR51">51</a></sup>. Hoechst 33,342 accumulates in the lipid membrane due to its hydrophobicity, but P-glycoprotein eliminates it<sup><a href="#CR52" class="usa-link" aria-describedby="CR52">52</a></sup>.</p>
<p id="Par53">DT blocked the efflux of Hoechst 33,342 mediated by P-gp and increased its accumulation in MCF-7 cells, as observed under a fluorescence microscope. (Fig. <a href="#Fig5" class="usa-link">5</a>). Our results are also consistent with the study of the properties of another flavonoid quercetin, which also decreased Hoechst 33,342 efflux by suppressing P-gp activity<sup><a href="#CR53" class="usa-link" aria-describedby="CR53">53</a></sup>.</p>
<p id="Par54">Furthermore, we have shown that DT affects not only P-gp activity but also expression at the mRNA and protein level, significantly decreasing both baseline in MCF-7 cells and those significantly increased by DOX (Fig. <a href="#Fig6" class="usa-link">6</a>).</p>
<p id="Par55">Although our study demonstrates that DT significantly reduces ABCB1/P-gp expression and functionally inhibits P-gp-mediated efflux—as shown by increased Hoechst 33,342 accumulation—definitive genetic evidence linking P-gp inhibition to enhanced DOX efficacy would provide further clarity. We recognize that approaches such as ABCB1 gene knockdown or knockout are valuable strategies to directly assess the causal role of P-gp in mediating resistance to DOX and its modulation by DT. These experiments would allow to determine whether DT still potentiates DOX cytotoxicity in the absence of functional P-gp and to what extent other pathways might be involved. While these studies were beyond the scope of the current investigation, they represent a critical next step.</p>
<p id="Par56">While our results demonstrate that DT significantly downregulates ABCB1 mRNA expression, the exact mechanism remains to be elucidated. Flavonoids have been shown to inhibit transcription factors such as NF-κB and AP-1, which regulate ABCB1 promoter activity<sup><a href="#CR54" class="usa-link" aria-describedby="CR54">54</a>,<a href="#CR55" class="usa-link" aria-describedby="CR55">55</a></sup>. Additionally, flavonoids may suppress ABCB1 through modulation of the PI3K/Akt/Nrf2 pathway, a known regulator of multidrug resistance genes<sup><a href="#CR56" class="usa-link" aria-describedby="CR56">56</a>,<a href="#CR57" class="usa-link" aria-describedby="CR57">57</a></sup>.</p>
<p id="Par57">Beyond ABCB1, other members of the ATP-binding cassette family, such as ABCG2 (BCRP) and ABCC1 (MRP1), play pivotal roles in multidrug resistance, particularly in breast cancers<sup><a href="#CR58" class="usa-link" aria-describedby="CR58">58</a></sup>. Flavonoids have demonstrated modulatory effects on these transporters<sup><a href="#CR59" class="usa-link" aria-describedby="CR59">59</a>,<a href="#CR60" class="usa-link" aria-describedby="CR60">60</a></sup>. Although not assessed in the present study, it is plausible that DT may also interact with BCRP or MRP1, potentially amplifying its capacity to reverse MDR.</p>
<p id="Par58">This research aimed to examine the anti-cancer potential of DT and to explore its underlying mechanisms in breast cancer cells, specifically focusing on its augmented effects with DOX. Previous studies confirmed DT’s capacity to trigger apoptosis and act as an anticancer agent in various cancer types. However, its impact on breast tumors and the development of MDR remains unclear. According to our research, DT shows potent therapeutic activities on breast cancer cell lines, with a particularly strong effect observed in the MCF-7 cell line. Significantly, we showed that DT treatment enhanced the anticancer activity of DOX. This study revealed that DT improved the efficacy of DOX by strongly suppressing <em>ABCB1</em> mRNA/protein levels and P-gp activity, thereby outlining a new approach to overcoming MDR in cancer cells. However, the augmentation of DOX cytotoxicity by DT is not solely due to the inhibition of the ABC transporter but also due to the accumulation of DNA damage. This indicates that DT enhances DOX efficacy by promoting DNA damage in tumors. These effects of DT on DOX anticancer properties may consequently augment apoptosis in MCF-7 cells, as confirmed by an appropriate assay. Considering DT’s well-documented safety in chronic venous disease, its repurposing for oncologic indications presents a promising opportunity for accelerated regulatory approval. The use of predictive biomarkers such as elevated ABCB1 expression or baseline P-gp activity may aid in selecting patients most responsive to DT co-treatment.</p></section><section id="Sec20"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par59">To conclude, our findings indicate that DT is a potent candidate for augmenting the effectiveness of breast cancer treatment. Its ability to improve the effects of DOX, overcome MDR, and establish DT as a valuable adjunctive therapy. Our investigations have revealed that DT induces cytotoxicity in breast cancer cell lines, connected with DNA damage. Moreover, it improves the effectiveness of DOX by decreasing the expression and activity of glycoprotein P, thereby increasing the concentration of the chemotherapeutic agent in the cell.</p>
<p id="Par60">Nevertheless, further in vivo research is essential to fully delineate DT’s impact of DT on breast cancer invasion, hypoxia-related processes, and its role in comprehensive anticancer strategies. While the current study offers strong in vitro evidence that DT enhances DOX efficacy via inhibition of P-gp and induction of DNA damage, we acknowledge that these findings require in vivo validation. Our study not only highlights the potential therapeutic application of DT in improving breast cancer therapies but also advocates for further investigation into clinical applications.</p></section><section id="Sec21"><h2 class="pmc_sec_title">Supplementary Information</h2>
<p>Below is the link to the electronic supplementary material.</p>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12371033/bin/41598_2025_16681_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (277.1KB, docx) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>M. Michalczyk- Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing—original draft. E.H.—Investigation, Methodology, Software, Data curation, Writing—review and editing. J.K.- Investigation, Formal analysis, Visualization, Writing—Review &amp; Editing.G.A.- Investigation, Methodology, Visualization, Writing—review and editing. M.Michalczuk- Investigation, Methodology. B.M.– C.- Formal analysis, Writing—Review &amp; Editing. M.C.- Methodology, Writing—Review &amp; Editing. A.K.-P.- Conceptualization, Formal analysis, Writing—Review &amp; Editing, Supervision.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research was funded by the Medical University of Lublin (Grant numbers: DS 37 and DS 706).</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>The datasets supporting the findings of this study can be obtained from the corresponding author upon reasonable request. All relevant data generated or analyzed in this research are fully available within the manuscript [and its supplementary information files].</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par61">The authors declare no competing interests.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher’s note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. <em>CA Cancer J. Clin.</em><strong>71</strong>, 209–249. 10.3322/caac.21660 (2021).
</cite> [<a href="https://doi.org/10.3322/caac.21660" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33538338/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Sung,%20H.%20et%20al.%20Global%20cancer%20statistics%202020:%20GLOBOCAN%20estimates%20of%20incidence%20and%20mortality%20worldwide%20for%2036%20cancers%20in%20185%20countries.%20CA%20Cancer%20J.%20Clin.71,%20209%E2%80%93249.%2010.3322/caac.21660%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Arnold, M. et al. Current and Future Burden of Breast Cancer: Global Statistics for 2020 and 2040. <em>Breast</em><strong>66</strong>, 15–23. 10.1016/j.breast.2022.08.010 (2022).
</cite> [<a href="https://doi.org/10.1016/j.breast.2022.08.010" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9465273/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36084384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Arnold,%20M.%20et%20al.%20Current%20and%20Future%20Burden%20of%20Breast%20Cancer:%20Global%20Statistics%20for%202020%20and%202040.%20Breast66,%2015%E2%80%9323.%2010.1016/j.breast.2022.08.010%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Wang, C. et al. Anti-Proliferation and Pro-Apoptotic effects of Diosmetin via modulating cell cycle arrest and Mitochondria-Mediated intrinsic apoptotic pathway in MDA-MB-231 cells. <em>Med. Sci. Monit.</em><strong>25</strong>, 4639–4647. 10.12659/MSM.914058 (2019).
</cite> [<a href="https://doi.org/10.12659/MSM.914058" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6601365/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31228347/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wang,%20C.%20et%20al.%20Anti-Proliferation%20and%20Pro-Apoptotic%20effects%20of%20Diosmetin%20via%20modulating%20cell%20cycle%20arrest%20and%20Mitochondria-Mediated%20intrinsic%20apoptotic%20pathway%20in%20MDA-MB-231%20cells.%20Med.%20Sci.%20Monit.25,%204639%E2%80%934647.%2010.12659/MSM.914058%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Ma, A. &amp; Zhang, R. Diosmetin inhibits cell proliferation, induces cell apoptosis and cell cycle arrest in liver cancer. <em>Cancer Manag Res.</em><strong>12</strong>, 3537–3546. 10.2147/CMAR.S240064 (2020).
</cite> [<a href="https://doi.org/10.2147/CMAR.S240064" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7244522/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32547191/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Ma,%20A.%20&amp;%20Zhang,%20R.%20Diosmetin%20inhibits%20cell%20proliferation,%20induces%20cell%20apoptosis%20and%20cell%20cycle%20arrest%20in%20liver%20cancer.%20Cancer%20Manag%20Res.12,%203537%E2%80%933546.%2010.2147/CMAR.S240064%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Koosha, S., Mohamed, Z., Sinniah, A. &amp; Alshawsh, M. A. Evaluation of Anti-Tumorigenic effects of Diosmetin against human colon cancer xenografts in athymic nude mice. <em>Molecules</em><strong>24</strong>, 2522. 10.3390/molecules24142522 (2019).
</cite> [<a href="https://doi.org/10.3390/molecules24142522" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6680397/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31295840/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koosha,%20S.,%20Mohamed,%20Z.,%20Sinniah,%20A.%20&amp;%20Alshawsh,%20M.%20A.%20Evaluation%20of%20Anti-Tumorigenic%20effects%20of%20Diosmetin%20against%20human%20colon%20cancer%20xenografts%20in%20athymic%20nude%20mice.%20Molecules24,%202522.%2010.3390/molecules24142522%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Roma, A., Rota, S. G. &amp; Spagnuolo, P. A. Diosmetin induces apoptosis of acute myeloid leukemia cells. <em>Mol. Pharm.</em><strong>15</strong>, 1353–1360. 10.1021/acs.molpharmaceut.7b01151 (2018).
</cite> [<a href="https://doi.org/10.1021/acs.molpharmaceut.7b01151" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29412683/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roma,%20A.,%20Rota,%20S.%20G.%20&amp;%20Spagnuolo,%20P.%20A.%20Diosmetin%20induces%20apoptosis%20of%20acute%20myeloid%20leukemia%20cells.%20Mol.%20Pharm.15,%201353%E2%80%931360.%2010.1021/acs.molpharmaceut.7b01151%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Zhao, F. et al. Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway. <em>Med. Oncol.</em><strong>38</strong>, 54. 10.1007/s12032-021-01501-1 (2021).
</cite> [<a href="https://doi.org/10.1007/s12032-021-01501-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33811596/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zhao,%20F.%20et%20al.%20Diosmetin%20induces%20apoptosis%20in%20ovarian%20cancer%20cells%20by%20activating%20reactive%20oxygen%20species%20and%20inhibiting%20the%20Nrf2%20pathway.%20Med.%20Oncol.38,%2054.%2010.1007/s12032-021-01501-1%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Liu, J. et al. Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP–2 and MMP–9. <em>Mol. Med. Rep.</em><strong>13</strong>, 2401–2408. 10.3892/mmr.2016.4872 (2016).
</cite> [<a href="https://doi.org/10.3892/mmr.2016.4872" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4768952/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26847170/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Liu,%20J.%20et%20al.%20Diosmetin%20inhibits%20the%20metastasis%20of%20hepatocellular%20carcinoma%20cells%20by%20downregulating%20the%20expression%20levels%20of%20MMP%E2%80%932%20and%20MMP%E2%80%939.%20Mol.%20Med.%20Rep.13,%202401%E2%80%932408.%2010.3892/mmr.2016.4872%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Oak, C. et al. Diosmetin suppresses human prostate cancer cell proliferation through the induction of apoptosis and cell cycle arrest. <em>Int. J. Oncol.</em><strong>53</strong>, 835–843. 10.3892/ijo.2018.4407 (2018).
</cite> [<a href="https://doi.org/10.3892/ijo.2018.4407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6017185/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29767250/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Oak,%20C.%20et%20al.%20Diosmetin%20suppresses%20human%20prostate%20cancer%20cell%20proliferation%20through%20the%20induction%20of%20apoptosis%20and%20cell%20cycle%20arrest.%20Int.%20J.%20Oncol.53,%20835%E2%80%93843.%2010.3892/ijo.2018.4407%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Feldo, M. et al. Effect of diosmin administration in patients with chronic venous disorders on selected factors affecting angiogenesis. <em>Molecules</em><strong>24</strong>, 3316. 10.3390/molecules24183316 (2019).
</cite> [<a href="https://doi.org/10.3390/molecules24183316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6767141/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31547271/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Feldo,%20M.%20et%20al.%20Effect%20of%20diosmin%20administration%20in%20patients%20with%20chronic%20venous%20disorders%20on%20selected%20factors%20affecting%20angiogenesis.%20Molecules24,%203316.%2010.3390/molecules24183316%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Maksimović, Z. V., Maksimović, M., Jadranin, D., Kuzmanović, I. &amp; Andonović, O. Medicamentous treatment of chronic venous insufficiency using semisynthetic Diosmin–a prospective study. <em>Acta Chir. Iugosl.</em><strong>55</strong>, 53–59. 10.2298/aci0804053m (2008).
</cite> [<a href="https://doi.org/10.2298/aci0804053m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19245142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Maksimovi%C4%87,%20Z.%20V.,%20Maksimovi%C4%87,%20M.,%20Jadranin,%20D.,%20Kuzmanovi%C4%87,%20I.%20&amp;%20Andonovi%C4%87,%20O.%20Medicamentous%20treatment%20of%20chronic%20venous%20insufficiency%20using%20semisynthetic%20Diosmin%E2%80%93a%20prospective%20study.%20Acta%20Chir.%20Iugosl.55,%2053%E2%80%9359.%2010.2298/aci0804053m%20(2008)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Campanero, M. A. et al. Simultaneous determination of diosmin and Diosmetin in human plasma by ion trap liquid Chromatography–Atmospheric pressure chemical ionization tandem mass spectrometry: application to a clinical Pharmacokinetic study. <em>J. Pharm. Biomed. Anal.</em><strong>51</strong>, 875–881. 10.1016/j.jpba.2009.09.012 (2010).
</cite> [<a href="https://doi.org/10.1016/j.jpba.2009.09.012" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19800189/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Campanero,%20M.%20A.%20et%20al.%20Simultaneous%20determination%20of%20diosmin%20and%20Diosmetin%20in%20human%20plasma%20by%20ion%20trap%20liquid%20Chromatography%E2%80%93Atmospheric%20pressure%20chemical%20ionization%20tandem%20mass%20spectrometry:%20application%20to%20a%20clinical%20Pharmacokinetic%20study.%20J.%20Pharm.%20Biomed.%20Anal.51,%20875%E2%80%93881.%2010.1016/j.jpba.2009.09.012%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>Cova, D., De Angelis, L., Giavarini, F., Palladini, G. &amp; Perego, R. Pharmacokinetics and metabolism of oral diosmin in healthy volunteers. <em>Int. J. Clin. Pharmacol. Ther. Toxicol.</em><strong>30</strong>, 29–33 (1992).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/1551741/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Cova,%20D.,%20De%20Angelis,%20L.,%20Giavarini,%20F.,%20Palladini,%20G.%20&amp;%20Perego,%20R.%20Pharmacokinetics%20and%20metabolism%20of%20oral%20diosmin%20in%20healthy%20volunteers.%20Int.%20J.%20Clin.%20Pharmacol.%20Ther.%20Toxicol.30,%2029%E2%80%9333%20(1992)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR14">
<span class="label">14.</span><cite>Serra, R. et al. Breast cancer and venous disease: A retrospective cohort study. <em>Ann. Vasc Surg.</em><strong>27</strong>, 762–766. 10.1016/j.avsg.2012.10.020 (2013).
</cite> [<a href="https://doi.org/10.1016/j.avsg.2012.10.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23809843/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Serra,%20R.%20et%20al.%20Breast%20cancer%20and%20venous%20disease:%20A%20retrospective%20cohort%20study.%20Ann.%20Vasc%20Surg.27,%20762%E2%80%93766.%2010.1016/j.avsg.2012.10.020%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Mclaughlin, M., Florida-James, G. &amp; Ross, M. Breast cancer chemotherapy vascular toxicity: A review of mediating mechanisms and exercise as a potential therapeutic. <em>Vasc Biol.</em><strong>3</strong>, R106–R120. 10.1530/VB-21-0013 (2021).
</cite> [<a href="https://doi.org/10.1530/VB-21-0013" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8630759/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34870095/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mclaughlin,%20M.,%20Florida-James,%20G.%20&amp;%20Ross,%20M.%20Breast%20cancer%20chemotherapy%20vascular%20toxicity:%20A%20review%20of%20mediating%20mechanisms%20and%20exercise%20as%20a%20potential%20therapeutic.%20Vasc%20Biol.3,%20R106%E2%80%93R120.%2010.1530/VB-21-0013%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Adamczuk, G. M., Humeniuk, E., Adamczuk, K., Madej-Czerwonka, B. &amp; Dudka, J. Disruption of mitochondrial function augments the radiosensitivity of prostate cancer cell lines. <em>Ann. Agric. Environ. Med.</em><strong>30</strong>, 65–76. 10.26444/aaem/155382 (2023).
</cite> [<a href="https://doi.org/10.26444/aaem/155382" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36999858/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Adamczuk,%20G.%20M.,%20Humeniuk,%20E.,%20Adamczuk,%20K.,%20Madej-Czerwonka,%20B.%20&amp;%20Dudka,%20J.%20Disruption%20of%20mitochondrial%20function%20augments%20the%20radiosensitivity%20of%20prostate%20cancer%20cell%20lines.%20Ann.%20Agric.%20Environ.%20Med.30,%2065%E2%80%9376.%2010.26444/aaem/155382%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Humeniuk, E. et al. Cardioprotective effect of Centaurea castriferrei Borbás &amp; Waisb extract against Doxorubicin-Induced cardiotoxicity in H9c2 cells. <em>Molecules</em><strong>28</strong>, 420. 10.3390/molecules28010420 (2023).
</cite> [<a href="https://doi.org/10.3390/molecules28010420" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9824364/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36615632/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Humeniuk,%20E.%20et%20al.%20Cardioprotective%20effect%20of%20Centaurea%20castriferrei%20Borb%C3%A1s%20&amp;%20Waisb%20extract%20against%20Doxorubicin-Induced%20cardiotoxicity%20in%20H9c2%20cells.%20Molecules28,%20420.%2010.3390/molecules28010420%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Olive, P. L. &amp; Banáth, J. P. The comet assay: A method to measure DNA damage in individual cells. <em>Nat. Protoc.</em><strong>1</strong>, 23–29. 10.1038/nprot.2006.5 (2006).
</cite> [<a href="https://doi.org/10.1038/nprot.2006.5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17406208/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Olive,%20P.%20L.%20&amp;%20Ban%C3%A1th,%20J.%20P.%20The%20comet%20assay:%20A%20method%20to%20measure%20DNA%20damage%20in%20individual%20cells.%20Nat.%20Protoc.1,%2023%E2%80%9329.%2010.1038/nprot.2006.5%20(2006)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Rasband, W. &amp; ImageJ, U. S. National Institutes of Health, Bethesda, Maryland, USA.; (2011).</cite>
</li>
<li id="CR20">
<span class="label">20.</span><cite>Rizvi, S. M. D., Shakil, S. &amp; Haneef Mohd. A simple click by click protocol to perform docking: AutoDock 4.2 made easy for Non-Bioinformaticians. <em>EXCLI J.</em><strong>12</strong>, 831–857 (2013).
</cite> [<a href="/articles/PMC4669947/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26648810/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Rizvi,%20S.%20M.%20D.,%20Shakil,%20S.%20&amp;%20Haneef%20Mohd.%20A%20simple%20click%20by%20click%20protocol%20to%20perform%20docking:%20AutoDock%204.2%20made%20easy%20for%20Non-Bioinformaticians.%20EXCLI%20J.12,%20831%E2%80%93857%20(2013)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Morris, G. M. et al. AutoDock4 and AutoDockTools4: automated Docking with selective receptor flexibility. <em>J. Comput. Chem.</em><strong>30</strong>, 2785–2791. 10.1002/jcc.21256 (2009).
</cite> [<a href="https://doi.org/10.1002/jcc.21256" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2760638/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19399780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Morris,%20G.%20M.%20et%20al.%20AutoDock4%20and%20AutoDockTools4:%20automated%20Docking%20with%20selective%20receptor%20flexibility.%20J.%20Comput.%20Chem.30,%202785%E2%80%932791.%2010.1002/jcc.21256%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Deeb, O., Rosales-Hernández, M. C., Gómez-Castro, C., Garduño-Juárez, R. &amp; Correa-Basurto, J. Exploration of human serum albumin binding sites by Docking and molecular dynamics flexible Ligand-Protein interactions. <em>Biopolymers</em><strong>93</strong>, 161–170. 10.1002/bip.21314 (2010).
</cite> [<a href="https://doi.org/10.1002/bip.21314" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19785033/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Deeb,%20O.,%20Rosales-Hern%C3%A1ndez,%20M.%20C.,%20G%C3%B3mez-Castro,%20C.,%20Gardu%C3%B1o-Ju%C3%A1rez,%20R.%20&amp;%20Correa-Basurto,%20J.%20Exploration%20of%20human%20serum%20albumin%20binding%20sites%20by%20Docking%20and%20molecular%20dynamics%20flexible%20Ligand-Protein%20interactions.%20Biopolymers93,%20161%E2%80%93170.%2010.1002/bip.21314%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Systèmes, D. &amp; Free Download BIOVIA Discovery Studio Visualizer Available online: <a href="https://discover.3ds.com/discovery-studio-visualizer-download" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://discover.3ds.com/discovery-studio-visualizer-download</a> (accessed on 28 March 2024).</cite>
</li>
<li id="CR24">
<span class="label">24.</span><cite>Kumar, A., Kalra, S., Jangid, K. &amp; Jaitak, V. Flavonoids as P-Glycoprotein inhibitors for multidrug resistance in cancer: an in-Silico approach. <em>J. Biomol. Struct. Dynamics</em>. <strong>41</strong>, 7627–7639. 10.1080/07391102.2022.2123390 (2023).</cite> [<a href="https://doi.org/10.1080/07391102.2022.2123390" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36120941/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kumar,%20A.,%20Kalra,%20S.,%20Jangid,%20K.%20&amp;%20Jaitak,%20V.%20Flavonoids%20as%20P-Glycoprotein%20inhibitors%20for%20multidrug%20resistance%20in%20cancer:%20an%20in-Silico%20approach.%20J.%20Biomol.%20Struct.%20Dynamics.%2041,%207627%E2%80%937639.%2010.1080/07391102.2022.2123390%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Di Veroli, G. Y. et al. Combenefit: an interactive platform for the analysis and visualization of drug combinations. <em>Bioinformatics</em><strong>32</strong>, 2866–2868. 10.1093/bioinformatics/btw230 (2016).
</cite> [<a href="https://doi.org/10.1093/bioinformatics/btw230" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5018366/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27153664/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Di%20Veroli,%20G.%20Y.%20et%20al.%20Combenefit:%20an%20interactive%20platform%20for%20the%20analysis%20and%20visualization%20of%20drug%20combinations.%20Bioinformatics32,%202866%E2%80%932868.%2010.1093/bioinformatics/btw230%20(2016)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR26">
<span class="label">26.</span><cite>Roy, I. M., Nadar, P. S. &amp; Khurana, S. Neutral comet assay to detect and quantitate DNA Double-Strand breaksin hematopoietic stem cells. <em>Bio Protoc.</em><strong>11</strong>, e4130. 10.21769/BioProtoc.4130 (2021).
</cite> [<a href="https://doi.org/10.21769/BioProtoc.4130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8413581/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34541048/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Roy,%20I.%20M.,%20Nadar,%20P.%20S.%20&amp;%20Khurana,%20S.%20Neutral%20comet%20assay%20to%20detect%20and%20quantitate%20DNA%20Double-Strand%20breaksin%20hematopoietic%20stem%20cells.%20Bio%20Protoc.11,%20e4130.%2010.21769/BioProtoc.4130%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Šimůnek, T. et al. Anthracycline-Induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron. <em>Pharmacol. Rep.</em><strong>61</strong>, 154–171. 10.1016/S1734-1140(09)70018-0 (2009).
</cite> [<a href="https://doi.org/10.1016/s1734-1140(09)70018-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19307704/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?%C5%A0im%C5%AFnek,%20T.%20et%20al.%20Anthracycline-Induced%20cardiotoxicity:%20overview%20of%20studies%20examining%20the%20roles%20of%20oxidative%20stress%20and%20free%20cellular%20iron.%20Pharmacol.%20Rep.61,%20154%E2%80%93171.%2010.1016/S1734-1140(09)70018-0%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Minotti, G. et al. Molecular advances and Pharmacologic developments in antitumor activity and cardiotoxicity. <em>Pharmacol. Rev.</em><strong>56</strong>, 185–229. 10.1124/pr.56.2.6 (2004).
</cite> [<a href="https://doi.org/10.1124/pr.56.2.6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15169927/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Minotti,%20G.%20et%20al.%20Molecular%20advances%20and%20Pharmacologic%20developments%20in%20antitumor%20activity%20and%20cardiotoxicity.%20Pharmacol.%20Rev.56,%20185%E2%80%93229.%2010.1124/pr.56.2.6%20(2004)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Denard, B., Jiang, S., Peng, Y. &amp; Ye, J. CREB3L1 as a potential biomarker predicting response of triple negative breast cancer to Doxorubicin-Based chemotherapy. <em>BMC Cancer</em>. <strong>18</strong>, 813. 10.1186/s12885-018-4724-8 (2018).
</cite> [<a href="https://doi.org/10.1186/s12885-018-4724-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6090630/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30103710/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Denard,%20B.,%20Jiang,%20S.,%20Peng,%20Y.%20&amp;%20Ye,%20J.%20CREB3L1%20as%20a%20potential%20biomarker%20predicting%20response%20of%20triple%20negative%20breast%20cancer%20to%20Doxorubicin-Based%20chemotherapy.%20BMC%20Cancer.%2018,%20813.%2010.1186/s12885-018-4724-8%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Christowitz, C. et al. Mechanisms of Doxorubicin-Induced drug resistance and drug resistant tumour growth in a murine breast tumour model. <em>BMC Cancer</em>. <strong>19</strong>, 757. 10.1186/s12885-019-5939-z (2019).
</cite> [<a href="https://doi.org/10.1186/s12885-019-5939-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6670209/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31370818/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Christowitz,%20C.%20et%20al.%20Mechanisms%20of%20Doxorubicin-Induced%20drug%20resistance%20and%20drug%20resistant%20tumour%20growth%20in%20a%20murine%20breast%20tumour%20model.%20BMC%20Cancer.%2019,%20757.%2010.1186/s12885-019-5939-z%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Yang, Y. et al. Diosmetin exerts Anti-Oxidative, Anti-Inflammatory and Anti-Apoptotic effects to protect against Endotoxin-Induced acute hepatic failure in mice. <em>Oncotarget</em><strong>8</strong>, 30723–30733. 10.18632/oncotarget.15413 (2017).
</cite> [<a href="https://doi.org/10.18632/oncotarget.15413" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5458162/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28430612/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang,%20Y.%20et%20al.%20Diosmetin%20exerts%20Anti-Oxidative,%20Anti-Inflammatory%20and%20Anti-Apoptotic%20effects%20to%20protect%20against%20Endotoxin-Induced%20acute%20hepatic%20failure%20in%20mice.%20Oncotarget8,%2030723%E2%80%9330733.%2010.18632/oncotarget.15413%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Wójciak, M. et al. Antioxidant potential of diosmin and Diosmetin against oxidative stress in endothelial cells. <em>Molecules</em><strong>27</strong>, 8232. 10.3390/molecules27238232 (2022).
</cite> [<a href="https://doi.org/10.3390/molecules27238232" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9739697/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36500323/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?W%C3%B3jciak,%20M.%20et%20al.%20Antioxidant%20potential%20of%20diosmin%20and%20Diosmetin%20against%20oxidative%20stress%20in%20endothelial%20cells.%20Molecules27,%208232.%2010.3390/molecules27238232%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Lee, D. H., Park, J. K., Choi, J., Jang, H. &amp; Seol, J. W. Anti-Inflammatory effects of natural flavonoid Diosmetin in IL-4 and LPS-Induced macrophage activation and atopic dermatitis model. <em>Int. Immunopharmacol.</em><strong>89</strong>, 107046. 10.1016/j.intimp.2020.107046 (2020).
</cite> [<a href="https://doi.org/10.1016/j.intimp.2020.107046" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7545212/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33045572/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lee,%20D.%20H.,%20Park,%20J.%20K.,%20Choi,%20J.,%20Jang,%20H.%20&amp;%20Seol,%20J.%20W.%20Anti-Inflammatory%20effects%20of%20natural%20flavonoid%20Diosmetin%20in%20IL-4%20and%20LPS-Induced%20macrophage%20activation%20and%20atopic%20dermatitis%20model.%20Int.%20Immunopharmacol.89,%20107046.%2010.1016/j.intimp.2020.107046%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Russo, R., Chandradhara, D. &amp; De Tommasi, N. Comparative bioavailability of two diosmin formulations after oral administration to healthy volunteers. <em>Molecules</em><strong>23</strong>, 2174. 10.3390/molecules23092174 (2018).
</cite> [<a href="https://doi.org/10.3390/molecules23092174" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6225479/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30158431/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Russo,%20R.,%20Chandradhara,%20D.%20&amp;%20De%20Tommasi,%20N.%20Comparative%20bioavailability%20of%20two%20diosmin%20formulations%20after%20oral%20administration%20to%20healthy%20volunteers.%20Molecules23,%202174.%2010.3390/molecules23092174%20(2018)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Gerges, S. H., Wahdan, S. A., Elsherbiny, D. A. &amp; El-Demerdash, E. Pharmacology of diosmin, a citrus flavone glycoside: an updated review. <em>Eur. J. Drug Metab. Pharmacokinet.</em><strong>47</strong>, 1–18. 10.1007/s13318-021-00731-y (2022).
</cite> [<a href="https://doi.org/10.1007/s13318-021-00731-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34687440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gerges,%20S.%20H.,%20Wahdan,%20S.%20A.,%20Elsherbiny,%20D.%20A.%20&amp;%20El-Demerdash,%20E.%20Pharmacology%20of%20diosmin,%20a%20citrus%20flavone%20glycoside:%20an%20updated%20review.%20Eur.%20J.%20Drug%20Metab.%20Pharmacokinet.47,%201%E2%80%9318.%2010.1007/s13318-021-00731-y%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Chen, X. et al. Profiling and comparison of the metabolites of Diosmetin and diosmin in rat urine, plasma and feces using UHPLC-LTQ-Orbitrap MSn. <em>J. Chromatogr. B Analyt Technol. Biomed. Life Sci.</em><strong>1124</strong>, 58–71. 10.1016/j.jchromb.2019.05.030 (2019).
</cite> [<a href="https://doi.org/10.1016/j.jchromb.2019.05.030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31177049/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20X.%20et%20al.%20Profiling%20and%20comparison%20of%20the%20metabolites%20of%20Diosmetin%20and%20diosmin%20in%20rat%20urine,%20plasma%20and%20feces%20using%20UHPLC-LTQ-Orbitrap%20MSn.%20J.%20Chromatogr.%20B%20Analyt%20Technol.%20Biomed.%20Life%20Sci.1124,%2058%E2%80%9371.%2010.1016/j.jchromb.2019.05.030%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>Burnouf, P. A., Roffler, S. R., Wu, C. C., Su, Y. C. &amp; Glucuronides From biological waste to Bio-Nanomedical applications. <em>J. Control Release</em>. <strong>349</strong>, 765–782. 10.1016/j.jconrel.2022.07.031 (2022).
</cite> [<a href="https://doi.org/10.1016/j.jconrel.2022.07.031" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35907593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Burnouf,%20P.%20A.,%20Roffler,%20S.%20R.,%20Wu,%20C.%20C.,%20Su,%20Y.%20C.%20&amp;%20Glucuronides%20From%20biological%20waste%20to%20Bio-Nanomedical%20applications.%20J.%20Control%20Release.%20349,%20765%E2%80%93782.%2010.1016/j.jconrel.2022.07.031%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Androutsopoulos, V. P., Mahale, S., Arroo, R. R. J. &amp; Potter, G. Anticancer effects of the flavonoid Diosmetin on cell cycle progression and proliferation of MDA-MB 468 breast cancer cells due to CYP1 activation. <em>Oncol. Rep.</em><strong>21</strong>, 1525–1528. 10.3892/or_00000384 (2009).
</cite> [<a href="https://doi.org/10.3892/or_00000384" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19424633/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Androutsopoulos,%20V.%20P.,%20Mahale,%20S.,%20Arroo,%20R.%20R.%20J.%20&amp;%20Potter,%20G.%20Anticancer%20effects%20of%20the%20flavonoid%20Diosmetin%20on%20cell%20cycle%20progression%20and%20proliferation%20of%20MDA-MB%20468%20breast%20cancer%20cells%20due%20to%20CYP1%20activation.%20Oncol.%20Rep.21,%201525%E2%80%931528.%2010.3892/or_00000384%20(2009)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Koosha, S., Mohamed, Z., Sinniah, A. &amp; Alshawsh, M. A. Investigation into the molecular mechanisms underlying the Anti-Proliferative and Anti-Tumorigenesis activities of Diosmetin against HCT-116 human colorectal cancer. <em>Sci. Rep.</em><strong>9</strong>, 5148. 10.1038/s41598-019-41685-1 (2019).
</cite> [<a href="https://doi.org/10.1038/s41598-019-41685-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6435658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30914796/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Koosha,%20S.,%20Mohamed,%20Z.,%20Sinniah,%20A.%20&amp;%20Alshawsh,%20M.%20A.%20Investigation%20into%20the%20molecular%20mechanisms%20underlying%20the%20Anti-Proliferative%20and%20Anti-Tumorigenesis%20activities%20of%20Diosmetin%20against%20HCT-116%20human%20colorectal%20cancer.%20Sci.%20Rep.9,%205148.%2010.1038/s41598-019-41685-1%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Kamran, S., Sinniah, A., Chik, Z. &amp; Alshawsh, M. A. Diosmetin exerts synergistic effects in combination with 5-fluorouracil in colorectal cancer cells. <em>Biomedicines</em>10.3390/biomedicines10030531 (2022).
</cite> [<a href="https://doi.org/10.3390/biomedicines10030531" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8945009/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35327333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kamran,%20S.,%20Sinniah,%20A.,%20Chik,%20Z.%20&amp;%20Alshawsh,%20M.%20A.%20Diosmetin%20exerts%20synergistic%20effects%20in%20combination%20with%205-fluorouracil%20in%20colorectal%20cancer%20cells.%20Biomedicines10.3390/biomedicines10030531%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Chen, X. et al. Diosmetin induces apoptosis and enhances the chemotherapeutic efficacy of Paclitaxel in Non-Small cell lung cancer cells via Nrf2 Inhibition. <em>Br. J. Pharmacol.</em><strong>176</strong>, 2079–2094. 10.1111/bph.14652 (2019).
</cite> [<a href="https://doi.org/10.1111/bph.14652" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6534779/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30825187/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20X.%20et%20al.%20Diosmetin%20induces%20apoptosis%20and%20enhances%20the%20chemotherapeutic%20efficacy%20of%20Paclitaxel%20in%20Non-Small%20cell%20lung%20cancer%20cells%20via%20Nrf2%20Inhibition.%20Br.%20J.%20Pharmacol.176,%202079%E2%80%932094.%2010.1111/bph.14652%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38439643/" class="text-red">Retracted</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Hu, Z. et al. Diosmetin enhances the sensitivity of radiotherapy by suppressing homologous recombination in endometrial cancer. <em>Cell Cycle</em><strong>19</strong>, 3115–3126. 10.1080/15384101.2020.1831257 (2020).
</cite> [<a href="https://doi.org/10.1080/15384101.2020.1831257" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7714470/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33064975/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hu,%20Z.%20et%20al.%20Diosmetin%20enhances%20the%20sensitivity%20of%20radiotherapy%20by%20suppressing%20homologous%20recombination%20in%20endometrial%20cancer.%20Cell%20Cycle19,%203115%E2%80%933126.%2010.1080/15384101.2020.1831257%20(2020)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Xu, Z. et al. Radiosensitizing effect of Diosmetin on radioresistant lung cancer cells via Akt signaling pathway. <em>PLOS ONE</em>. <strong>12</strong>, e0175977. 10.1371/journal.pone.0175977 (2017).
</cite> [<a href="https://doi.org/10.1371/journal.pone.0175977" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5393875/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28414793/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Xu,%20Z.%20et%20al.%20Radiosensitizing%20effect%20of%20Diosmetin%20on%20radioresistant%20lung%20cancer%20cells%20via%20Akt%20signaling%20pathway.%20PLOS%20ONE.%2012,%20e0175977.%2010.1371/journal.pone.0175977%20(2017)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR44">
<span class="label">44.</span><cite>Yang, X. et al. MDR1 gene expression in primary and advanced breast cancer. <em>Lab. Invest.</em><strong>79</strong>, 271–280 (1999).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/10092063/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yang,%20X.%20et%20al.%20MDR1%20gene%20expression%20in%20primary%20and%20advanced%20breast%20cancer.%20Lab.%20Invest.79,%20271%E2%80%93280%20(1999)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR45">
<span class="label">45.</span><cite>Zyad, A., Bénard, J., Tursz, T., Clarke, R. &amp; Chouaib, S. Resistance to TNF-alpha and adriamycin in the human breast cancer MCF-7 cell line: Relationship to MDR1, MnSOD, and TNF gene expression. <em>Cancer Res.</em> (1994).</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/7905787/" class="usa-link">PubMed</a>]</li>
<li id="CR46">
<span class="label">46.</span><cite>Váradi, A., Szakács, G., Bakos, E. &amp; Sarkadi, B. P. Glycoprotein and the mechanism of multidrug resistance. <em>Novartis Found. Symp.</em><strong>243</strong>, 54–65 (2002).
</cite> [<a href="https://pubmed.ncbi.nlm.nih.gov/11990782/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?V%C3%A1radi,%20A.,%20Szak%C3%A1cs,%20G.,%20Bakos,%20E.%20&amp;%20Sarkadi,%20B.%20P.%20Glycoprotein%20and%20the%20mechanism%20of%20multidrug%20resistance.%20Novartis%20Found.%20Symp.243,%2054%E2%80%9365%20(2002)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR47">
<span class="label">47.</span><cite>Kathawala, R. J., Gupta, P., Ashby, C. R. &amp; Chen, Z. S. The modulation of ABC Transporter-Mediated multidrug resistance in cancer: A review of the past decade. <em>Drug Resist. Updat</em>. <strong>18</strong>, 1–17. 10.1016/j.drup.2014.11.002 (2015).
</cite> [<a href="https://doi.org/10.1016/j.drup.2014.11.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25554624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kathawala,%20R.%20J.,%20Gupta,%20P.,%20Ashby,%20C.%20R.%20&amp;%20Chen,%20Z.%20S.%20The%20modulation%20of%20ABC%20Transporter-Mediated%20multidrug%20resistance%20in%20cancer:%20A%20review%20of%20the%20past%20decade.%20Drug%20Resist.%20Updat.%2018,%201%E2%80%9317.%2010.1016/j.drup.2014.11.002%20(2015)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR48">
<span class="label">48.</span><cite>Mirzaei, S. et al. Advances in Understanding the role of P-Gp in doxorubicin resistance: molecular pathways, therapeutic strategies, and prospects. <em>Drug Discovery Today</em>. <strong>27</strong>, 436–455. 10.1016/j.drudis.2021.09.020 (2022).
</cite> [<a href="https://doi.org/10.1016/j.drudis.2021.09.020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34624510/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mirzaei,%20S.%20et%20al.%20Advances%20in%20Understanding%20the%20role%20of%20P-Gp%20in%20doxorubicin%20resistance:%20molecular%20pathways,%20therapeutic%20strategies,%20and%20prospects.%20Drug%20Discovery%20Today.%2027,%20436%E2%80%93455.%2010.1016/j.drudis.2021.09.020%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR49">
<span class="label">49.</span><cite>Paškevičiūtė, M. &amp; Petrikaitė, V. Effect of natural flavonoids to reverse P-Glycoprotein-Related multidrug resistance in breast cancer cell cultures. <em>Am. J. Cancer Res.</em><strong>12</strong>, 2526–2538 (2022).
</cite> [<a href="/articles/PMC9251692/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35812069/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pa%C5%A1kevi%C4%8Di%C5%ABt%C4%97,%20M.%20&amp;%20Petrikait%C4%97,%20V.%20Effect%20of%20natural%20flavonoids%20to%20reverse%20P-Glycoprotein-Related%20multidrug%20resistance%20in%20breast%20cancer%20cell%20cultures.%20Am.%20J.%20Cancer%20Res.12,%202526%E2%80%932538%20(2022)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR50">
<span class="label">50.</span><cite>Yoo, H. H., Lee, M., Chung, H. J., Lee, S. K. &amp; Kim, D. H. Effects of diosmin, a flavonoid glycoside in citrus fruits, on P-Glycoprotein-Mediated drug efflux in human intestinal Caco-2 cells. <em>J. Agric. Food Chem.</em><strong>55</strong>, 7620–7625. 10.1021/jf070893f (2007).
</cite> [<a href="https://doi.org/10.1021/jf070893f" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17676865/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yoo,%20H.%20H.,%20Lee,%20M.,%20Chung,%20H.%20J.,%20Lee,%20S.%20K.%20&amp;%20Kim,%20D.%20H.%20Effects%20of%20diosmin,%20a%20flavonoid%20glycoside%20in%20citrus%20fruits,%20on%20P-Glycoprotein-Mediated%20drug%20efflux%20in%20human%20intestinal%20Caco-2%20cells.%20J.%20Agric.%20Food%20Chem.55,%207620%E2%80%937625.%2010.1021/jf070893f%20(2007)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR51">
<span class="label">51.</span><cite>Lahmy, S., Viallet, P. &amp; Salmon, J. M. Is reduced accumulation of Hoechst 33342 in multidrug resistant cells related to P-Glycoprotein activity?? <em>Cytometry</em><strong>19</strong>, 126–133. 10.1002/cyto.990190207 (1995).
</cite> [<a href="https://doi.org/10.1002/cyto.990190207" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7743893/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lahmy,%20S.,%20Viallet,%20P.%20&amp;%20Salmon,%20J.%20M.%20Is%20reduced%20accumulation%20of%20Hoechst%2033342%20in%20multidrug%20resistant%20cells%20related%20to%20P-Glycoprotein%20activity??%20Cytometry19,%20126%E2%80%93133.%2010.1002/cyto.990190207%20(1995)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR52">
<span class="label">52.</span><cite>Shapiro, A. B., Corder, A. B. &amp; Ling, V. P. Hoechst 33342 transport out of the lipid bilayer. <em>Eur. J. Biochem.</em><strong>250</strong>, 115–121. 10.1111/j.1432-1033.1997.00115.x (1997).
</cite> [<a href="https://doi.org/10.1111/j.1432-1033.1997.00115.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9431998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shapiro,%20A.%20B.,%20Corder,%20A.%20B.%20&amp;%20Ling,%20V.%20P.%20Hoechst%2033342%20transport%20out%20of%20the%20lipid%20bilayer.%20Eur.%20J.%20Biochem.250,%20115%E2%80%93121.%2010.1111/j.1432-1033.1997.00115.x%20(1997)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR53">
<span class="label">53.</span><cite>Shapiro, A. B. &amp; Ling, V. Effect of Quercetin on Hoechst 33342 transport by purified and reconstituted P-Glycoprotein. <em>Biochem. Pharmacol.</em><strong>53</strong>, 587–596. 10.1016/s0006-2952(96)00826-x (1997).
</cite> [<a href="https://doi.org/10.1016/s0006-2952(96)00826-x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9105411/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Shapiro,%20A.%20B.%20&amp;%20Ling,%20V.%20Effect%20of%20Quercetin%20on%20Hoechst%2033342%20transport%20by%20purified%20and%20reconstituted%20P-Glycoprotein.%20Biochem.%20Pharmacol.53,%20587%E2%80%93596.%2010.1016/s0006-2952(96)00826-x%20(1997)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR54">
<span class="label">54.</span><cite>Quercetin and Doxorubicin Co-Delivery Using β-Cyclodextrin Nanocarrier Overcomes Multi-Drug Resistance in Cancer Cells via Targeting Akt/NF-κB/ABCB1 Signaling Pathway | Request PDF. ResearchGate. (2025). 10.1007/s42247-024-00845-4</cite>
</li>
<li id="CR55">
<span class="label">55.</span><cite>Bharathiraja, P., Yadav, P., Sajid, A., Ambudkar, S. V. &amp; Prasad, N. R. Natural medicinal compounds target signal transduction pathways to overcome ABC drug efflux Transporter-Mediated multidrug resistance in cancer. <em>Drug Resist. Updat</em>. <strong>71</strong>, 101004. 10.1016/j.drup.2023.101004 (2023).
</cite> [<a href="https://doi.org/10.1016/j.drup.2023.101004" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10840887/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37660590/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bharathiraja,%20P.,%20Yadav,%20P.,%20Sajid,%20A.,%20Ambudkar,%20S.%20V.%20&amp;%20Prasad,%20N.%20R.%20Natural%20medicinal%20compounds%20target%20signal%20transduction%20pathways%20to%20overcome%20ABC%20drug%20efflux%20Transporter-Mediated%20multidrug%20resistance%20in%20cancer.%20Drug%20Resist.%20Updat.%2071,%20101004.%2010.1016/j.drup.2023.101004%20(2023)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR56">
<span class="label">56.</span><cite>Zughaibi, T. A., Suhail, M., Tarique, M. &amp; Tabrez, S. Targeting PI3K/Akt/mTOR pathway by different flavonoids: A cancer chemopreventive approach. <em>Int. J. Mol. Sci.</em><strong>22</strong>, 12455. 10.3390/ijms222212455 (2021).
</cite> [<a href="https://doi.org/10.3390/ijms222212455" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8621356/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34830339/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Zughaibi,%20T.%20A.,%20Suhail,%20M.,%20Tarique,%20M.%20&amp;%20Tabrez,%20S.%20Targeting%20PI3K/Akt/mTOR%20pathway%20by%20different%20flavonoids:%20A%20cancer%20chemopreventive%20approach.%20Int.%20J.%20Mol.%20Sci.22,%2012455.%2010.3390/ijms222212455%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR57">
<span class="label">57.</span><cite>Muthusamy, G., Gunaseelan, S. &amp; Prasad, N. R. Ferulic acid reverses P-Glycoprotein-Mediated multidrug resistance via Inhibition of PI3K/Akt/NF-κB signaling pathway. <em>J. Nutr. Biochem.</em><strong>63</strong>, 62–71. 10.1016/j.jnutbio.2018.09.022 (2019).
</cite> [<a href="https://doi.org/10.1016/j.jnutbio.2018.09.022" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30342318/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Muthusamy,%20G.,%20Gunaseelan,%20S.%20&amp;%20Prasad,%20N.%20R.%20Ferulic%20acid%20reverses%20P-Glycoprotein-Mediated%20multidrug%20resistance%20via%20Inhibition%20of%20PI3K/Akt/NF-%CE%BAB%20signaling%20pathway.%20J.%20Nutr.%20Biochem.63,%2062%E2%80%9371.%2010.1016/j.jnutbio.2018.09.022%20(2019)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR58">
<span class="label">58.</span><cite>Natarajan, K., Xie, Y., Baer, M. R. &amp; Ross, D. D. Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance. <em>Biochem. Pharmacol.</em><strong>83</strong>, 1084–1103. 10.1016/j.bcp.2012.01.002 (2012).
</cite> [<a href="https://doi.org/10.1016/j.bcp.2012.01.002" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3307098/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22248732/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Natarajan,%20K.,%20Xie,%20Y.,%20Baer,%20M.%20R.%20&amp;%20Ross,%20D.%20D.%20Role%20of%20breast%20cancer%20resistance%20protein%20(BCRP/ABCG2)%20in%20cancer%20drug%20resistance.%20Biochem.%20Pharmacol.83,%201084%E2%80%931103.%2010.1016/j.bcp.2012.01.002%20(2012)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR59">
<span class="label">59.</span><cite>Alvarez, A. I. et al. Modulation of the activity of ABC transporters (P-Glycoprotein, MRP2, BCRP) by flavonoids and drug response. <em>J. Pharm. Sci.</em><strong>99</strong>, 598–617. 10.1002/jps.21851 (2010).
</cite> [<a href="https://doi.org/10.1002/jps.21851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19544374/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alvarez,%20A.%20I.%20et%20al.%20Modulation%20of%20the%20activity%20of%20ABC%20transporters%20(P-Glycoprotein,%20MRP2,%20BCRP)%20by%20flavonoids%20and%20drug%20response.%20J.%20Pharm.%20Sci.99,%20598%E2%80%93617.%2010.1002/jps.21851%20(2010)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR60">
<span class="label">60.</span><cite>Chen, X. Y., Wang, J. Q., Yang, Y., Li, J. &amp; Chen, Z. S. Natural product as substrates of ABC transporters: A review. <em>Recent. Pat. Anticancer Drug Discov</em>. <strong>16</strong>, 222–238. 10.2174/1574892816666210218220943 (2021).
</cite> [<a href="https://doi.org/10.2174/1574892816666210218220943" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33602076/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Chen,%20X.%20Y.,%20Wang,%20J.%20Q.,%20Yang,%20Y.,%20Li,%20J.%20&amp;%20Chen,%20Z.%20S.%20Natural%20product%20as%20substrates%20of%20ABC%20transporters:%20A%20review.%20Recent.%20Pat.%20Anticancer%20Drug%20Discov.%2016,%20222%E2%80%93238.%2010.2174/1574892816666210218220943%20(2021)." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12371033/bin/41598_2025_16681_MOESM1_ESM.docx" data-ga-action="click_feat_suppl" class="usa-link">Supplementary Material 1</a><sup> (277.1KB, docx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>The datasets supporting the findings of this study can be obtained from the corresponding author upon reasonable request. All relevant data generated or analyzed in this research are fully available within the manuscript [and its supplementary information files].</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Scientific Reports are provided here courtesy of <strong>Nature Publishing Group</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1038/s41598-025-16681-3"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/41598_2025_Article_16681.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12371033/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12371033/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12371033%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12371033/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12371033/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12371033/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40841424/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12371033/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40841424/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12371033/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12371033/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="6X8uxE6SV9mwzxt2xMmuVOgH1x9418W7920wZXNQkazYXqEr0QvKzXVFKPRCvK6k">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
